← All blog posts

Autoimmune Hepatitis Themes in People with IBD

Posted on August 7, 2026 · Associations

Content note: Educational content aligned with publicly available patient materials from the Crohn's & Colitis Foundation and other major IBD education sources. Content is used under license from the Foundation for patient education; the Foundation does not endorse IBDPal or MediVue products or services. Last reviewed June 2026. Not individual medical advice.

Educational use only. IBDPal does not provide medical advice, diagnosis, or treatment. Always consult your gastroenterologist or IBD care team for personal decisions.

Liver enzyme changes in IBD have many causes: medicines, fatty liver, viral infection, bile-duct disease such as PSC, or less often autoimmune hepatitis patterns. This short article is for orientation, not self-diagnosis.

Why the distinction matters

Autoimmune hepatitis is treated differently from PSC and from drug-induced liver injury. Your team may order autoantibody panels, imaging, or a biopsy. Immunosuppression plans can overlap with IBD therapy, so GI and hepatology need a shared timeline.

Overlap reading

Place this beside autoimmune overlap and fatigue in autoimmune IBD. Medication side effects still belong in the differential every time labs rise.

Related: research sources, visit prep.

Read the full interactive version on ibdpal.org.